arrow
P

Pavitra Roychoudhury

university of washington
H指数:41
被引数:6,202

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tecovirimat treatment of clade II mpox: a virological analysis of a randomised, double-blind, phase 3 trial

tecovirimat治疗II型猴痘:一项随机、双盲、III期试验的病毒学分析

2026-07-290
OAAI
Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study

儿童中与SARS-CoV-2感染风险相关的免疫相关性:一项前瞻性、社区为基础的队列研究

2026-07-180
OAAI
Viral variant but not host factors associate with SARS-CoV-2 viral kinetics

病毒变体而非宿主因素与SARS-CoV-2病毒动力学相关联

2026-04-170
OAAI
HIV-seq reveals gene expression differences between HIV-transcribing cells from viremic and suppressed people with HIV

HIV-seq揭示了来自病毒血症抑制者和病毒受抑制的HIV感染者中HIV转录细胞之间的基因表达差异。

2026-03-030
OA
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

SARS-CoV-2变异株抗体反应的免疫相关性分析:ENSEMBLE疫苗有效性试验

2025-09-290
OAAI
Clinical Performance Evaluation of a Tiling Amplicon Panel for Whole-Genome Sequencing of Respiratory Syncytial Virus

用于呼吸道合胞病毒全基因组测序的拼接扩增子面板的临床性能评估

2025-06-190
OA
Serum factors create species-specific barriers to hepatic gene transfer by lipid nanoparticles in liver-humanized mice

血清因子通过脂质纳米颗粒在人类化小鼠肝脏中形成种属特异性屏障,阻碍肝脏基因转移。

2025-06-010
OAAI
Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation

SARS-CoV-2核衣壳中的变异突变G215C通过改变基因组衣壳化增强病毒感染。

2025-04-290
OA
Fine-scale patterns of SARS-CoV-2 spread from identical pathogen sequences

相同病原体序列的SARS-CoV-2传播的精细尺度模式

Nature
IF48.5
2025-03-050
OA
Household Transmission and Genomic Diversity of Respiratory Syncytial Virus (RSV) in the United States, 2022-2023
2025-03-010
PRE
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
2025-02-010
PRE
Clinical and Genomic Epidemiology of Coxsackievirus A21 and Enterovirus D68 in Homeless Shelters, King County, Washington, USA, 2019-2021
2024-11-010
PRE
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
2024-03-112
OAAI